Ronald Krall, MD
Adjunct Associate Professor of Neurology
University of Pittsburgh
Dr. Krall is Adjunct Associate Professor of Neurology and Member of the Center for Health Law and Bioethics at the University of Pittsburgh and a collaborator in the Observational Health Data Sciences and Informatics (OHDSI) project. He is a member of the Board of the Foundation of the NIH, of the Scientific Advisory Board of Kala Pharmaceuticals, of the Safety Board of Takeda Pharmaceuticals and consults for a number of healthcare companies.
Former Chief Medical Officer for GlaxoSmithKline (Retired), Dr. Krall worked for four companies (Lorex Pharmaceuticals, Abbott Laboratories, Zeneca/AstraZeneca and GlaxoSmithKline) over 25 years. His areas of expertise include the ethics of human subject experimentation, drug development, regulatory science and the safety of medicines. Dr. Krall was a founding member of the Observational Medical Outcomes Partnership, served on its Executive Committee and led its research subcommittee.
